Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice.

Weissmann N, Peters DM, Klöpping C, Krüger K, Pilat C, Katta S, Seimetz M, Ghofrani HA, Schermuly RT, Witzenrath M, Seeger W, Grimminger F, Mooren FC.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 1;306(11):L986-95. doi: 10.1152/ajplung.00275.2013. Epub 2014 Apr 4.

2.

Sildenafil improves microvascular O2 delivery-to-utilization matching and accelerates exercise O2 uptake kinetics in chronic heart failure.

Sperandio PA, Oliveira MF, Rodrigues MK, Berton DC, Treptow E, Nery LE, Almeida DR, Neder JA.

Am J Physiol Heart Circ Physiol. 2012 Dec 15;303(12):H1474-80. doi: 10.1152/ajpheart.00435.2012. Epub 2012 Sep 28.

3.

Sildenafil and phosphodiesterase-5 inhibitors for heart failure.

Guazzi M.

Curr Heart Fail Rep. 2008 Jun;5(2):110-4. Review.

PMID:
18765082
4.

Sildenafil in the treatment of pulmonary hypertension.

Barnett CF, Machado RF.

Vasc Health Risk Manag. 2006;2(4):411-22. Review.

5.

The emerging role for type 5 phosphodiesterase inhibition in heart failure.

Lewis GD, Semigran MJ.

Curr Heart Fail Rep. 2006 Sep;3(3):123-8. Review.

PMID:
16914104
6.
7.

Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors.

Carson CC 3rd.

Am J Cardiol. 2005 Dec 26;96(12B):37M-41M. Epub 2005 Dec 5. Review.

PMID:
16387565
9.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.

N Engl J Med. 2005 Nov 17;353(20):2148-57. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1.

11.

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

Richalet JP, Gratadour P, Robach P, Pham I, Déchaux M, Joncquiert-Latarjet A, Mollard P, Brugniaux J, Cornolo J.

Am J Respir Crit Care Med. 2005 Feb 1;171(3):275-81. Epub 2004 Oct 29.

PMID:
15516532
12.

Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.

[No authors listed]

Ann Intern Med. 2004 Aug 3;141(3):I12. No abstract available.

PMID:
15289233
13.

Sildenafil for enhanced performance at high altitude?

Rubin LJ, Naeije R.

Ann Intern Med. 2004 Aug 3;141(3):233-5. No abstract available.

PMID:
15289224
14.

Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.

Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, Seeger W, Grimminger F.

Ann Intern Med. 2004 Aug 3;141(3):169-77.

PMID:
15289213
15.

Role of the cardiologist: clinical aspects of managing erectile dysfunction.

Hutter AM Jr.

Clin Cardiol. 2004 Apr;27(4 Suppl 1):I3-7. Review.

16.

The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.

Bharani A, Mathew V, Sahu A, Lunia B.

Indian Heart J. 2003 Jan-Feb;55(1):55-9.

PMID:
12760589
17.

[Cardio-vascular effects of sildenafil: new data].

Danchin N.

Ann Cardiol Angeiol (Paris). 2002 Dec;51(6):341-5. Review. French.

PMID:
12608126

Supplemental Content

Loading ...
Support Center